A detailed history of Kbc Group Nv transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 351 shares of MDGL stock, worth $76,167. This represents 0.0% of its overall portfolio holdings.

Number of Shares
351
Previous 259 35.52%
Holding current value
$76,167
Previous $69,000 42.03%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$193.33 - $291.99 $17,786 - $26,863
92 Added 35.52%
351 $98,000
Q4 2023

Feb 13, 2024

BUY
$120.4 - $237.13 $31,183 - $61,416
259 New
259 $60,000
Q3 2023

Feb 15, 2024

BUY
$146.04 - $225.78 $5,403 - $8,353
37 Added 14.29%
296 $43,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $3.71B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.